3 Cash-Heavy Stocks on Our Watchlist

Companies with more cash than debt often have stronger financial flexibility, making them attractive in uncertain markets. With interest payments less of a worry, these businesses can invest more in growth, innovation, or buybacks and dividends.

Not all companies with sound capital structures are created equal, and StockStory is here to help you find the best. Keeping that in mind, here are three companies with net cash positions that can leverage their balance sheets to grow.

Powell (POWL)

Net Cash Position: $544 million (7.1% of Market Cap)

Originally a metal-working shop supporting local petrochemical facilities, Powell (NYSE:POWL) has grown from a small Houston manufacturer to a global provider of electrical systems.

Why Will POWL Beat the Market?

1. Annual revenue growth of 15.4% over the last two years was superb and indicates its market share increased during this cycle
2. Additional sales over the last two years increased its profitability as the 36.7% annual growth in its earnings per share outpaced its revenue
3. Free cash flow margin grew by 22.8 percentage points over the last five years, giving the company more chips to play with

At $212.37 per share, Powell trades at 32.1x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.

Tutor Perini (TPC)

Net Cash Position: $671.5 million (15.3% of Market Cap)

Known for constructing the Philadelphia Eagles’ Stadium, Tutor Perini (NYSE:TPC) is a civil and building construction company offering diversified general contracting and design-build services.

Why Are We Positive on TPC?

1. Annual revenue growth of 17% over the past two years was outstanding, reflecting market share gains this cycle
2. Earnings growth has massively outpaced its peers over the last two years as its EPS has compounded at 102% annually
3. Free cash flow margin grew by 12.9 percentage points over the last five years, giving the company more chips to play with

Tutor Perini is trading at $83.30 per share, or 14x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.

Medpace (MEDP)

Net Cash Position: $358.6 million (2.2% of Market Cap)

Founded in 1992 as a scientifically-driven alternative to traditional contract research organizations, Medpace (NASDAQ:MEDP) provides outsourced clinical trial management and research services to help pharmaceutical, biotechnology, and medical device companies develop new treatments.

Why Do We Watch MEDP?

1. Existing business lines can expand without risky acquisitions as its organic revenue growth averaged 17.2% over the past two years
2. Share repurchases have amplified shareholder returns as its annual earnings per share growth of 29.6% exceeded its revenue gains over the last five years
3. Free cash flow margin expanded by 6 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends

Medpace’s stock price of $579.40 implies a valuation ratio of 31.7x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.